Papers: 10.3390/cancers13153871
https://doi.org/10.3390/cancers13153871
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
Cited by: 8
Author(s): Emma Rodrı́guez, Guangsheng Pei, Sang T. Kim, Alexis German, Prema Robinson
Published: about 5 years ago
Software Mentions 2
bioconductor: DESeq2
Differential gene expression analysis based on the negative binomial distributionPapers that mentioned: 9,583
Very Likely Science (100)
Very Likely Science (100)